Sintilimab with Interleukin-2+CAPOX
PRSYM202310
Phase 2 small_molecule completed
Quick answer
Sintilimab with Interleukin-2+CAPOX for Locally Advanced Rectal Adenocarcinoma is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Locally Advanced Rectal Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed